|
1
|
Nguyen QT, Lee EJ, Huang MG, Park YI,
Khullar A and Plodkowski RA: Diagnosis and treatment of patients
with thyroid cancer. Am Health Drug Benefits. 8:30–40.
2015.PubMed/NCBI
|
|
2
|
Feldt-Rasmussen U and Rasmussen AK:
Autoimmunity in differentiated thyroid cancer: Significance and
related clinical problems. Hormones (Athens). 9:109–117. 2010.
View Article : Google Scholar
|
|
3
|
Carling T and Udelsman R: Thyroid cancer.
Annu Rev Med. 65:125–137. 2014. View Article : Google Scholar
|
|
4
|
Smallridge RC, Marlow LA and Copland JA:
Anaplastic thyroid cancer: Molecular pathogenesis and emerging
therapies. Endocr Relat Cancer. 16:17–44. 2009. View Article : Google Scholar
|
|
5
|
Hébrant A, Floor S, Saiselet M, Antoniou
A, Desbuleux A, Snyers B, La C, de Saint Aubain N, Leteurtre E,
Andry G, et al: miRNA expression in anaplastic thyroid carcinomas.
PLoS One. 9:e1038712014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hébrant A, Dom G, Dewaele M, Andry G,
Trésallet C, Leteurtre E, Dumont JE and Maenhaut C: mRNA expression
in papillary and anaplastic thyroid carcinoma: Molecular anatomy of
a killing switch. PLoS One. 7:e378072012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kunstman JW, Juhlin CC, Goh G, Brown TC,
Stenman A, Healy JM, Rubinstein JC, Choi M, Kiss N, Nelson-Williams
C, et al: Characterization of the mutational landscape of
anaplastic thyroid cancer via whole-exome sequencing. Hum Mol
Genet. 24:2318–2329. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wilkens L, Benten D, Tchinda J, Brabant G,
Pötter E, Dralle H and von Wasielewski R: Aberrations of
chromosomes 5 and 8 as recurrent cytogenetic events in anaplastic
carcinoma of the thyroid as detected by fluorescence in situ
hybridisation and comparative genomic hybridisation. Virchows Arch.
436:312–318. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
von Roemeling CA, Marlow LA, Pinkerton AB,
Crist A, Miller J, Tun HW, Smallridge RC and Copland JA: Aberrant
lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl
CoA desaturase 1 as a novel therapeutic target. J Clin Endocrinol
Metab. 100:E697–E709. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Berger B, Peng J and Singh M:
Computational solutions for omics data. Nat Rev Genet. 14:333–346.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dom G, Tarabichi M, Unger K, Thomas G,
Oczko-Wojciechowska M, Bogdanova T, Jarzab B, Dumont JE, Detours V
and Maenhaut C: A gene expression signature distinguishes normal
tissues of sporadic and radiation-induced papillary thyroid
carcinomas. Br J Cancer. 107:994–1000. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gentleman RC, Carey VJ, Bates DM, Bolstad
B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al:
Bioconductor: Open software development for computational biology
and bioinformatics. Genome Biol. 5:R802004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kerr MK: Linear models for microarray data
analysis: Hidden similarities and differences. J Comput Biol.
10:891–901. 2003. View Article : Google Scholar
|
|
14
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for Annotation,
Visualization, and Integrated Discovery. Genome Biol. 4:32003.
View Article : Google Scholar
|
|
15
|
Harris MA, Clark J, Ireland A, Lomax J,
Ashburner M, Foulger R, Eilbeck K, Lewis S, Marshall B, Mungall C,
et al: Gene Ontology Consortium: The Gene Ontology (GO) database
and informatics resource. Nucleic Acids Res. 32:D258–D261. 2004.
View Article : Google Scholar
|
|
16
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar
|
|
17
|
Warde-Farley D, Donaldson SL, Comes O,
Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT,
et al: The GeneMANIA prediction server: Biological network
integration for gene prioritization and predicting gene function.
Nucleic Acids Res. 38:W214–W220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kutmon M, Kelder T, Mandaviya P, Evelo CT
and Coort SL: CyTargetLinker: A cytoscape app to integrate
regulatory interactions in network analysis. PLoS One.
8:e821602013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hsu SD, Lin FM, Wu WY, Liang C, Huang WC,
Chan WL, Tsai WT, Chen GZ, Lee CJ, Chiu CM, et al: miRTarBase: A
database curates experimentally validated microRNA-target
interactions. Nucleic Acids Res. 39:D163–D169. 2011. View Article : Google Scholar
|
|
20
|
Azizi G and Malchoff CD: Autoimmune
thyroid disease: A risk factor for thyroid cancer. Endocr Pract.
17:201–209. 2011. View Article : Google Scholar
|
|
21
|
Ma R, Latif R and Davies TF: Thyroid
follicle formation and thyroglobulin expression in multipotent
endodermal stem cells. Thyroid. 23:385–391. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Khan MS, Pandith AA, Masoodi SR, Wani KA,
Ul Hussain M and Mudassar S: Epigenetic silencing of TSHR gene in
thyroid cancer patients in relation to their BRAF V600E mutation
status. Endocrine. 47:449–455. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xing M, Usadel H, Cohen Y, Tokumaru Y, Guo
Z, Westra WB, Tong BC, Tallini G, Udelsman R, Califano JA, et al:
Methylation of the thyroid-stimulating hormone receptor gene in
epithelial thyroid tumors: A marker of malignancy and a cause of
gene silencing. Cancer Res. 63:2316–2321. 2003.PubMed/NCBI
|
|
24
|
Smith JA, Fan CY, Zou C, Bodenner D and
Kokoska MS: Methylation status of genes in papillary thyroid
carcinoma. Arch Otolaryngol Head Neck Surg. 133:1006–1011. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kowalska A, Pałyga I, Gąsior-Perczak D,
Walczyk A, Trybek T, Słuszniak A, Mężyk R and Góźdź S: The cut-off
level of recombinant human TSH-stimulated thyroglobulin in the
follow-up of patients with differentiated thyroid cancer. PLoS One.
10:e01338522015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Teama SH, Agwa SH, Fawzy A, Sayed MM,
Ibrahim WA and Eid YM: Molecular detection of circulating thyroid
specific transcripts (TSHR/Tg-mRNAs) in thyroid cancer patients:
Their diagnostic significance. Egypt J Med Hum Genet. 12:201–209.
2011. View Article : Google Scholar
|
|
27
|
Nishida N, Yano H, Nishida T, Kamura T and
Kojiro M: Angiogenesis in cancer. Vasc Health Risk Manag.
2:213–219. 2006. View Article : Google Scholar
|
|
28
|
Ip W, Wellman-Labadie O, Tang L, Su M, Yu
R, Dutz J, Wang Y, Huang S, Zhang X, Huang C, et al: Collagen
triple helix repeat containing 1 promotes melanoma cell adhesion
and survival. J Cutan Med Surg. 15:103–110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
LeClair R and Lindner V: The role of
collagen triple helix repeat containing 1 in injured arteries,
collagen expression, and transforming growth factor beta signaling.
Trends Cardiovasc Med. 17:202–205. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Durmus T, LeClair RJ, Park KS, Terzic A,
Yoon JK and Lindner V: Expression analysis of the novel gene
collagen triple helix repeat containing-1 (Cthrc1). Gene Expr
Patterns. 6:935–940. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tang L, Dai DL, Su M, Martinka M, Li G and
Zhou Y: Aberrant expression of collagen triple helix repeat
containing 1 in human solid cancers. Clin Cancer Res. 12:3716–3722.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Turashvili G, Bouchal J, Ehrmann J,
Fridman E, Skarda J and Kolar Z: Novel immunohistochemical markers
for the differentiation of lobular and ductal invasive breast
carcinomas. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub.
151:59–64. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pyagay P, Heroult M, Wang Q, Lehnert W,
Belden J, Liaw L, Friesel RE and Lindner V: Collagen triple helix
repeat containing 1, a novel secreted protein in injured and
diseased arteries, inhibits collagen expression and promotes cell
migration. Circ Res. 96:261–268. 2005. View Article : Google Scholar
|
|
34
|
Ke Z, He W, Lai Y, Guo X, Chen S, Li S,
Wang Y and Wang L: Overexpression of collagen triple helix repeat
containing 1 (CTHRC1) is associated with tumour aggressiveness and
poor prognosis in human non-small cell lung cancer. Oncotarget.
5:9410–9424. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang W and Yee AJ: Versican V2 isoform
enhances angiogenesis by regulating endothelial cell activities and
fibronectin expression. FEBS Lett. 587:185–192. 2013. View Article : Google Scholar
|
|
36
|
Zheng PS, Wen J, Ang LC, Sheng W,
Viloria-Petit A, Wang Y, Wu Y, Kerbel RS and Yang BB: Versican/PG-M
G3 domain promotes tumor growth and angiogenesis. FASEB J.
18:754–756. 2004.PubMed/NCBI
|
|
37
|
Zhang Z, Nie F, Chen X, Qin Z, Kang C,
Chen B, Ma J, Pan B and Ma Y: Upregulated periostin promotes
angiogenesis in keloids through activation of the ERK 1/2 and focal
adhesion kinase pathways, as well as the upregulated expression of
VEGF and angiopoietin 1. Mol Med Rep. 11:857–864. 2015.
|
|
38
|
Shao R, Bao S, Bai X, Blanchette C,
Anderson RM, Dang T, Gishizky ML, Marks JR and Wang XF: Acquired
expression of periostin by human breast cancers promotes tumor
angiogenesis through up-regulation of vascular endothelial growth
factor receptor 2 expression. Mol Cell Biol. 24:3992–4003. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhu M, Fejzo MS, Anderson L, Dering J,
Ginther C, Ramos L, Gasson JC, Karlan BY and Slamon DJ: Periostin
promotes ovarian cancer angiogenesis and metastasis. Gynecol Oncol.
119:337–344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kunstman JW, Juhlin CC, Goh G, Brown TC,
Stenman A, Healy JM, Rubinstein JC, Choi M, Kiss N, Nelson-Williams
C, et al: Characterization of the mutational landscape of
anaplastic thyroid cancer via whole-exome sequencing. Hum Mol
Genet. 24:2318–2329. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kveiborg M, Fröhlich C, Albrechtsen R,
Tischler V, Dietrich N, Holck P, Kronqvist P, Rank F, Mercurio AM
and Wewer UM: A role for ADAM12 in breast tumor progression and
stromal cell apoptosis. Cancer Res. 65:4754–4761. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cheon DJ, Li AJ, Beach JA, Walts AE, Tran
H, Lester J, Karlan BY and Orsulic S: ADAM12 is a prognostic factor
associated with an aggressive molecular subtype of high-grade
serous ovarian carcinoma. Carcinogenesis. 36:739–747. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Larsen M, Tremblay ML and Yamada KM:
Phosphatases in cell-matrix adhesion and migration. Nat Rev Mol
Cell Biol. 4:700–711. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Murasawa Y, Hayashi T and Wang P-C: The
role of type V collagen fibril as an ECM that induces the motility
of glomerular endothelial cells. Exp Cell Res. 314:3638–3653. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Berchtold S, Grünwald B, Krüger A,
Reithmeier A, Hähl T, Cheng T, Feuchtinger A, Born D, Erkan M,
Kleeff J, et al: Collagen type V promotes the malignant phenotype
of pancreatic ductal adenocarcinoma. Cancer Lett. 356:721–732.
2015. View Article : Google Scholar
|
|
46
|
Fischer H, Stenling R, Rubio C and
Lindblom A: Colorectal carcinogenesis is associated with stromal
expression of COL11A1 and COL5A2. Carcinogenesis. 22:875–878. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhou W, Wang Z, Shen N, Pi W, Jiang W,
Huang J, Hu Y, Li X and Sun L: Knockdown of ANLN by lentivirus
inhibits cell growth and migration in human breast cancer. Mol Cell
Biochem. 398:11–19. 2015. View Article : Google Scholar
|
|
48
|
Pandi NS, Manimuthu M, Harunipriya P,
Murugesan M, Asha GV and Rajendran S: In silico analysis of
expression pattern of a Wnt/β-catenin responsive gene ANLN in
gastric cancer. Gene. 545:23–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Pardo LA and Stühmer W: The roles of K(+)
channels in cancer. Nat Rev Cancer. 14:39–48. 2014. View Article : Google Scholar
|
